Estetrol for treatment of advanced ER+ breast cancer

被引：0
|
作者：
Schmidt, M.
Honig, A.
Verhoeven, C.
Almstedt, K.
Battista, M.
Lenhard, H. G.
Krijgh, J.
Bennink, H. Coelingh
机构：
[1] Johannes Gutenberg Univ Mainz, Klin & Poliklin Geburtshilfe & Frauengesundheit, Mainz, Germany
[2] Katholisches Klinikum Mainz, Gebuttshilfe & Frauenheilkunde, Mainz, Germany
[3] Pantarhei Oncol BV, Zeist, Netherlands
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-P4-13-12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-13-12
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Estetrol for treatment of advanced ER+ breast cancer
    Verhoeven, Carole
    Schmidt, Marcus
    Hoenig, Arnd
    Duennebacke, Jan
    Dutman, Ellen
    Krijgh, Jan
    Bennink, Herjan Coelingh
    [J]. CANCER RESEARCH, 2018, 78 (04)
  • [2] Estetrol for treatment of advanced ER+/HER2-breast cancer
    Schmidt, Marcus
    Hoenig, Arnd
    Zimmerman, Yvette
    Verhoeven, Carole
    Almstedt, Katrin
    Battista, Marco
    Lenhard, Hans Georg
    Krijgh, Jan
    Bennink, Herjan Coelingh
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [3] ABCE4 study: estetrol for treatment of advanced ER plus breast cancer
    Verhoeven, C.
    Schmidt, M.
    Dutman, A.
    Bennink, H. C.
    [J]. BREAST, 2017, 32 : S69 - S70
  • [4] Treatment of ER+/HER2+breast cancer
    Johnston, Stephen
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [5] Methylome Variation Predicts Exemestane Resistance in Advanced ER+ Breast Cancer
    Liu, Xiao-ran
    Zhang, Ru-yan
    Gong, Hao
    Rugo, Hope S.
    Chen, Ling-bo
    Fu, Yuan
    Che, Jian-wei
    Tie, Jian
    Shao, Bin
    Wan, Feng-ling
    Kong, Wei-yao
    Song, Guo-hong
    Jiang, Han-fang
    Xu, Guo-bing
    Li, Hui-ping
    [J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2020, 19
  • [6] Wise and skillful utilization of contemporary endocrine therapies for the treatment of ER+/HER2- advanced breast cancer
    Wysocki, J.
    [J]. ONCOLOGY IN CLINICAL PRACTICE, 2024, 20 (04): : 291 - 301
  • [7] Modeling ER+ breast cancer dormancy in mice
    Alexandra Le Bras
    [J]. Lab Animal, 2022, 51 : 285 - 285
  • [8] Clinical study of first-line endocrine therapy for type ER+/PR+ and ER+/PR- advanced breast cancer
    Zhang, Mengwei
    Yan, Min
    Lv, Huimin
    Niu, Limin
    Zeng, Huiai
    [J]. ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (01) : 238 - 243
  • [9] Selective Estrogen Receptor Modulators (SERMs) for the treatment of ER+ breast cancer: An overview
    Das, Sweety
    Kulkarni, Swanand
    Singh, Yogesh
    Kumar, Pradeep
    Thareja, Suresh
    [J]. Journal of Molecular Structure, 2022, 1270
  • [10] Hippo signalling maintains ER expression and ER+ breast cancer growth
    Ma, Shenghong
    Wu, Zhengming
    Yang, Feng
    Zhang, Jianmin
    Johnson, Randy L.
    Rosenfeld, Michael G.
    Guan, Kun-Liang
    [J]. NATURE, 2021, 591 (7848) : E1 - E10
12345